Search Results

Golvatinib (E7050) 100mg  | 98%

APEXBIO TECHNOLOGY LLC

C-Met/VEGFR-2 inhibitor Tyrosine Kinase|c-MET

More Information Supplier Page

×

Golvatinib (E7050)

Golvatinib (E7050) 50mg  | 98%

APEXBIO TECHNOLOGY LLC

C-Met/VEGFR-2 inhibitor Tyrosine Kinase|c-MET

More Information Supplier Page

×

Golvatinib (E7050)

Golvatinib (E7050) 20mg  | 98%

APEXBIO TECHNOLOGY LLC

C-Met/VEGFR-2 inhibitor Tyrosine Kinase|c-MET

More Information Supplier Page

×

Golvatinib (E7050)

Golvatinib (E7050) 10mg  | 98%

APEXBIO TECHNOLOGY LLC

C-Met/VEGFR-2 inhibitor Tyrosine Kinase|c-MET

More Information Supplier Page

×

Golvatinib (E7050)

BMS-794833 Evaluation Sample  | 99.73%

APEXBIO TECHNOLOGY LLC

Met/VEGFR-2 inhibitor,potent and ATP-competitive Tyrosine Kinase|c-MET

More Information Supplier Page

×

BMS-794833

BMS-794833 5mg  | 99.73%

APEXBIO TECHNOLOGY LLC

Met/VEGFR-2 inhibitor,potent and ATP-competitive Tyrosine Kinase|c-MET

More Information Supplier Page

×

BMS-794833

BMS-794833 10mg  | 99.73%

APEXBIO TECHNOLOGY LLC

Met/VEGFR-2 inhibitor,potent and ATP-competitive Tyrosine Kinase|c-MET

More Information Supplier Page

×

BMS-794833

BMS-794833 50mg  | 99.73%

APEXBIO TECHNOLOGY LLC

Met/VEGFR-2 inhibitor,potent and ATP-competitive Tyrosine Kinase|c-MET

More Information Supplier Page

×

BMS-794833

Golvatinib (E7050) 10mM (in 1mL DMSO)  | 98%

APEXBIO TECHNOLOGY LLC

C-Met/VEGFR-2 inhibitor Tyrosine Kinase|c-MET

More Information Supplier Page

×

Golvatinib (E7050)

PF-477736 10mM (in 1mL DMSO)  | 98.01%

APEXBIO TECHNOLOGY LLC

Chk1 inhibitor Cell Cycle/Checkpoint|Chk

More Information Supplier Page

×

PF-477736